LENNAR CORP-A (LEN) Fundamental Analysis & Valuation

NYSE:LEN • US5260571048

96.95 USD
-1.77 (-1.79%)
Last: Mar 11, 2026, 02:31 PM

This LEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

LEN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Household Durables industry. LEN has only an average score on both its financial health and profitability. LEN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. LEN Profitability Analysis

1.1 Basic Checks

  • In the past year LEN was profitable.
  • In the past year LEN had a positive cash flow from operations.
  • LEN had positive earnings in each of the past 5 years.
  • Each year in the past 5 years LEN had a positive operating cash flow.
LEN Yearly Net Income VS EBIT VS OCF VS FCFLEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • LEN's Return On Assets of 5.98% is fine compared to the rest of the industry. LEN outperforms 63.33% of its industry peers.
  • The Return On Equity of LEN (9.37%) is comparable to the rest of the industry.
  • LEN's Return On Invested Capital of 6.47% is in line compared to the rest of the industry. LEN outperforms 50.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LEN is in line with the industry average of 9.06%.
Industry RankSector Rank
ROA 5.98%
ROE 9.37%
ROIC 6.47%
ROA(3y)8.44%
ROA(5y)10.1%
ROE(3y)12.66%
ROE(5y)15.59%
ROIC(3y)9.8%
ROIC(5y)11.6%
LEN Yearly ROA, ROE, ROICLEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of LEN (6.02%) is better than 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of LEN has declined.
  • Looking at the Operating Margin, with a value of 8.09%, LEN is in line with its industry, outperforming 56.67% of the companies in the same industry.
  • LEN's Operating Margin has declined in the last couple of years.
  • LEN has a worse Gross Margin (10.38%) than 95.00% of its industry peers.
  • LEN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.09%
PM (TTM) 6.02%
GM 10.38%
OM growth 3Y-27%
OM growth 5Y-11.92%
PM growth 3Y-23.69%
PM growth 5Y-11.09%
GM growth 3Y-20.86%
GM growth 5Y-8.29%
LEN Yearly Profit, Operating, Gross MarginsLEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

6

2. LEN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LEN is creating some value.
  • Compared to 1 year ago, LEN has less shares outstanding
  • LEN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for LEN is higher compared to a year ago.
LEN Yearly Shares OutstandingLEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LEN Yearly Total Debt VS Total AssetsLEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • LEN has an Altman-Z score of 3.87. This indicates that LEN is financially healthy and has little risk of bankruptcy at the moment.
  • LEN's Altman-Z score of 3.87 is fine compared to the rest of the industry. LEN outperforms 66.67% of its industry peers.
  • The Debt to FCF ratio of LEN is 208.46, which is on the high side as it means it would take LEN, 208.46 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of LEN (208.46) is worse than 70.00% of its industry peers.
  • A Debt/Equity ratio of 0.27 indicates that LEN is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.27, LEN perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 208.46
Altman-Z 3.87
ROIC/WACC0.75
WACC8.61%
LEN Yearly LT Debt VS Equity VS FCFLEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • LEN has a Current Ratio of 8.22. This indicates that LEN is financially healthy and has no problem in meeting its short term obligations.
  • LEN has a Current ratio of 8.22. This is amongst the best in the industry. LEN outperforms 85.00% of its industry peers.
  • LEN has a Quick Ratio of 2.52. This indicates that LEN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.52, LEN belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.22
Quick Ratio 2.52
LEN Yearly Current Assets VS Current LiabilitesLEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

5

3. LEN Growth Analysis

3.1 Past

  • The earnings per share for LEN have decreased strongly by -44.28% in the last year.
  • LEN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.33% yearly.
  • LEN shows a decrease in Revenue. In the last year, the revenue decreased by -3.54%.
  • The Revenue has been growing by 8.74% on average over the past years. This is quite good.
EPS 1Y (TTM)-44.28%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.46%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-5.82%

3.2 Future

  • Based on estimates for the next years, LEN will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
  • LEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.26% yearly.
EPS Next Y-13.78%
EPS Next 2Y3.89%
EPS Next 3Y12.03%
EPS Next 5Y25.99%
Revenue Next Year-1.68%
Revenue Next 2Y1.52%
Revenue Next 3Y3.9%
Revenue Next 5Y7.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LEN Yearly Revenue VS EstimatesLEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
LEN Yearly EPS VS EstimatesLEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

3

4. LEN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.13 indicates a correct valuation of LEN.
  • LEN's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.25, LEN is valued rather cheaply.
  • A Price/Forward Earnings ratio of 14.07 indicates a correct valuation of LEN.
  • The rest of the industry has a similar Price/Forward Earnings ratio as LEN.
  • LEN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.13
Fwd PE 14.07
LEN Price Earnings VS Forward Price EarningsLEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • LEN's Enterprise Value to EBITDA is on the same level as the industry average.
  • 71.67% of the companies in the same industry are cheaper than LEN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 851.81
EV/EBITDA 9.16
LEN Per share dataLEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • LEN's earnings are expected to grow with 12.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)36.92
EPS Next 2Y3.89%
EPS Next 3Y12.03%

6

5. LEN Dividend Analysis

5.1 Amount

  • LEN has a Yearly Dividend Yield of 1.92%.
  • Compared to an average industry Dividend Yield of 1.24, LEN pays a bit more dividend than its industry peers.
  • LEN's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

  • The dividend of LEN is nicely growing with an annual growth rate of 26.65%!
  • LEN has paid a dividend for at least 10 years, which is a reliable track record.
  • LEN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)26.65%
Div Incr Years1
Div Non Decr Years15
LEN Yearly Dividends per shareLEN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • LEN pays out 25.31% of its income as dividend. This is a sustainable payout ratio.
  • LEN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP25.31%
EPS Next 2Y3.89%
EPS Next 3Y12.03%
LEN Yearly Income VS Free CF VS DividendLEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
LEN Dividend Payout.LEN Dividend Payout, showing the Payout Ratio.LEN Dividend Payout.PayoutRetained Earnings

LEN Fundamentals: All Metrics, Ratios and Statistics

LENNAR CORP-A

NYSE:LEN (3/11/2026, 2:31:08 PM)

96.95

-1.77 (-1.79%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)12-16
Earnings (Next)03-12
Inst Owners93.57%
Inst Owner Change-2.99%
Ins Owners0.29%
Ins Owner Change4.04%
Market Cap24.01B
Revenue(TTM)34.19B
Net Income(TTM)2.06B
Analysts53.08
Price Target111.12 (14.62%)
Short Float %4.12%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend2.02
Dividend Growth(5Y)26.65%
DP25.31%
Div Incr Years1
Div Non Decr Years15
Ex-Date02-04
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.91%
Min EPS beat(2)-13.73%
Max EPS beat(2)7.91%
EPS beat(4)2
Avg EPS beat(4)-0.42%
Min EPS beat(4)-13.73%
Max EPS beat(4)11.86%
EPS beat(8)5
Avg EPS beat(8)4.01%
EPS beat(12)9
Avg EPS beat(12)8.75%
EPS beat(16)11
Avg EPS beat(16)4.95%
Revenue beat(2)1
Avg Revenue beat(2)-0.1%
Min Revenue beat(2)-3.05%
Max Revenue beat(2)2.85%
Revenue beat(4)3
Avg Revenue beat(4)0.78%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)2.85%
Revenue beat(8)5
Avg Revenue beat(8)0.29%
Revenue beat(12)9
Avg Revenue beat(12)2.51%
Revenue beat(16)11
Avg Revenue beat(16)1.94%
PT rev (1m)0%
PT rev (3m)-14.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-40.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.72%
Valuation
Industry RankSector Rank
PE 12.13
Fwd PE 14.07
P/S 0.7
P/FCF 851.81
P/OCF 110.73
P/B 1.09
P/tB 1.31
EV/EBITDA 9.16
EPS(TTM)7.99
EY8.24%
EPS(NY)6.89
Fwd EY7.11%
FCF(TTM)0.11
FCFY0.12%
OCF(TTM)0.88
OCFY0.9%
SpS138.06
BVpS88.68
TBVpS74.01
PEG (NY)N/A
PEG (5Y)36.92
Graham Number126.27
Profitability
Industry RankSector Rank
ROA 5.98%
ROE 9.37%
ROCE 8.55%
ROIC 6.47%
ROICexc 7.33%
ROICexgc 12.52%
OM 8.09%
PM (TTM) 6.02%
GM 10.38%
FCFM 0.08%
ROA(3y)8.44%
ROA(5y)10.1%
ROE(3y)12.66%
ROE(5y)15.59%
ROIC(3y)9.8%
ROIC(5y)11.6%
ROICexc(3y)11.51%
ROICexc(5y)13.4%
ROICexgc(3y)16.28%
ROICexgc(5y)17.35%
ROCE(3y)12.94%
ROCE(5y)15.31%
ROICexgc growth 3Y-14.76%
ROICexgc growth 5Y1.92%
ROICexc growth 3Y-24.72%
ROICexc growth 5Y-5.18%
OM growth 3Y-27%
OM growth 5Y-11.92%
PM growth 3Y-23.69%
PM growth 5Y-11.09%
GM growth 3Y-20.86%
GM growth 5Y-8.29%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 208.46
Debt/EBITDA 2.03
Cap/Depr 140.44%
Cap/Sales 0.55%
Interest Coverage 55.18
Cash Conversion 7.47%
Profit Quality 1.37%
Current Ratio 8.22
Quick Ratio 2.52
Altman-Z 3.87
F-Score5
WACC8.61%
ROIC/WACC0.75
Cap/Depr(3y)126.5%
Cap/Depr(5y)104.2%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.35%
Profit Quality(3y)63.09%
Profit Quality(5y)63.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-44.28%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.46%
EPS Next Y-13.78%
EPS Next 2Y3.89%
EPS Next 3Y12.03%
EPS Next 5Y25.99%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-5.82%
Revenue Next Year-1.68%
Revenue Next 2Y1.52%
Revenue Next 3Y3.9%
Revenue Next 5Y7.26%
EBIT growth 1Y-46.35%
EBIT growth 3Y-26.63%
EBIT growth 5Y-4.23%
EBIT Next Year-17.49%
EBIT Next 3Y10.01%
EBIT Next 5Y18.06%
FCF growth 1Y-98.74%
FCF growth 3Y-79.37%
FCF growth 5Y-63.1%
OCF growth 1Y-90.98%
OCF growth 3Y-59.51%
OCF growth 5Y-44.7%

LENNAR CORP-A / LEN FAQ

What is the ChartMill fundamental rating of LENNAR CORP-A (LEN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to LEN.


What is the valuation status for LEN stock?

ChartMill assigns a valuation rating of 3 / 10 to LENNAR CORP-A (LEN). This can be considered as Overvalued.


How profitable is LENNAR CORP-A (LEN) stock?

LENNAR CORP-A (LEN) has a profitability rating of 4 / 10.


How financially healthy is LENNAR CORP-A?

The financial health rating of LENNAR CORP-A (LEN) is 6 / 10.


Is the dividend of LENNAR CORP-A sustainable?

The dividend rating of LENNAR CORP-A (LEN) is 6 / 10 and the dividend payout ratio is 25.31%.